Product
Description
Semaglutide is a glucagon-like peptide-1
receptor agonist. It is an antidiabetic medication used for the treatment of
type 2 diabetes and an anti-obesity medication used for long-term weight
management. Semaglutide is not for use in people with type 1 diabetes.
Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic
control in patients. The higher-dose formulation of Semaglutide is indicated as
an adjunct to diet and exercise for long-term weight management in adults with
obesity (initial body mass index (BMI) ≥ 30 kg/m2) or who are overweight
(initial BMI ≥ 27 kg/m2) and have at least one weight-related comorbidity.
Action:
Semaglutide reduces high blood sugar by
increasing the amount of insulin released, decreasing the amount of glucagon
released, and delaying gastric emptying. Semaglutide also controls appetite and
helps reduce the amount of food a person wants to eat. In addition, Semaglutide
reduces preference for high-fat meals.
Dosage:
The beginning dose is 0.25 mg once a week for the first 4 weeks. This
will help give your body a chance to get used to the medicine. At Week 5, your
health care professional will increase the dose to 0.5 mg once a
week.combination with any AAS.
- Stock: In Stock